Published in Vaccine Weekly, May 15th, 2002
Recent experiments in mice have shown that binding a monoclonal antibody to 4-1BB activates this costimulatory molecule and triggers a strong immune response. Based on this knowledge, Karl Erik Hellstrom and colleagues at the Pacific Northwest Research Institute in Seattle have developed a form of gene therapy to treat cancer. They inserted...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly